跳至主要内容
临床试验/NCT00166829
NCT00166829Unknown4 期

The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus

National Taiwan University Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2004年5月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
40
试验地点
2
主要终点
The influence of sirolimus on the pharmacokinetics of tacrolimus in renal transplant patients

研究概览

简要总结

The purpose of this study is to understand whether the pharmacokinetics of tacrolimus is influenced by the concurrent use of sirolimus.

详细描述

The controlled clinical trial held in NTUH in 2001 revealed that the bioavailability of tacrolimus when combined with sirolimus is lower than that reported in the literature where tacrolimus was not combined with sirolimus. To determine if the difference was due to the drug interaction between sirolimus and tacrolimus, a controlled clinical trial was proposed.

The purpose of this study is to understand whether the pharmacokinetics of tacrolimus is influenced by the concurrent use of sirolimus.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
13 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • De novo kidney transplant patients
  • Aged 13 - 65 years
  • Having aminotransferase concentrations within 2 times the upper limit of normal

排除标准

  • Pregnancy
  • Tuberculosis
  • Hepatitis B or C carrier status
  • Human immunodeficiency virus-positive status
  • Retransplantation or multi-organ transplantation
  • History of rheumatoid arthritis

结局指标

主要结局

The influence of sirolimus on the pharmacokinetics of tacrolimus in renal transplant patients

次要结局

  • Compare the outcome of tacrolimus/sirolimus and tacrolimus/mycophenolate in rejection prevention

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验